PWA
KYMR icon

Physician Wealth Advisors’s Kymera Therapeutics KYMR Stock Holding History

Physician Wealth Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803 Buy
+7
New +$601 ﹤0.01% 1913

Other funds holding KYMR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KMWM
Keudell/Morrison Wealth Management Salem, Oregon $529M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Physician Wealth Advisors's KYMR Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 7 shares worth $803. The stake represents ﹤0.01% of the portfolio and ranks #1913 among its holdings.

17 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Physician Wealth Advisors held 7 shares of Kymera Therapeutics worth $803 as of Q2 2026.
  • Kymera Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1913 holding.
  • 17 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.